⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1226994 | 0.67 | — | — | |
| SCHEMBL15017786 | 0.67 | — | — | |
| SCHEMBL34508 | 0.59 | — | — | |
| SCHEMBL28820 | 0.59 | — | — | |
| SCHEMBL323342 | 0.59 | — | — | |
| SCHEMBL8841030 | 0.59 | — | — | |
| SCHEMBL28819 | 0.59 | — | — | |
| SCHEMBL8841031 | 0.59 | — | — | |
| SCHEMBL2771000 | 0.56 | — | — | |
| SCHEMBL1316019 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 890 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3674298-B9 | SUBSTITUTED INDAZOLES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL FORMULATIONS CONTAINING THEM, AND THEIR USE FOR THE PREPARATION OF MEDICAMENTS | Bayer Pharma AG (DE) | 2024-06-19 | — | — | EP | claimed |
| US-12006303-B2 | Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugs | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2024-06-11 | — | — | US | claimed |
| WO-2024108010-A1 | METHODS AND COMPOSITIONS FOR CONTROL OF PAIN AND INFLAMMATION | BAYER ANIMAL HEALTH GMBH (DE) | 2024-05-23 | — | — | WO | claimed |
| CN-117999515-A | Photosensitive composition, cured product, display device, electronic component, and method for producing cured product | 东丽株式会社 | 2024-05-07 | — | — | CN | claimed |
| WO-2024010784-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS | VIVIDION THERAPEUTICS, INC. (US) | 2024-01-11 | — | — | WO | claimed |
| EP-3674298-B1 | SUBSTITUTED INDAZOLES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL FORMULATIONS CONTAINING THEM, AND THEIR USE FOR THE PREPARATION OF MEDICAMENTS | Bayer Pharma AG (DE) | 2024-01-10 | — | — | EP | claimed |
| EP-3872061-B1 | 1-PHENYL-2-PHENYLETHANE DERIVATIVE | KAO CORP (JP) | 2023-12-27 | — | — | EP | claimed |
| US-20230365524-A1 | 2,4,5-TRISUBSTITUTED 1,2,4-TRIAZOLONES USEFUL AS INHIBITORS OF DHODH | BAYER AKTIENGESELLSCHAFT (DE) | 2023-11-16 | — | — | US | claimed |
| EP-4260909-A2 | SUBSTITUTED INDAZOLES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THEIR USE IN THE PREPARATION OF DRUGS | Bayer Pharma Aktiengesellschaft (DE) | 2023-10-18 | — | — | EP | claimed |
| US-11713304-B2 | 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH | BAYER AKTIENGESELLSCHAFT (DE) | 2023-08-01 | — | — | US | claimed |
| US-6019986-A | Parasiticidal pyrazoles | PFIZER INC. (US) | 2000-02-01 | — | — | US | claimed |
| EP-0933363-A1 | Parasiticidal pyrazoles | Pfizer Limited (GB) | 1999-08-04 | — | — | EP | claimed |
| EP-0708101-B1 | Piperidine derivatives, useful as neurokinin receptor antagonists | ADIR (FR) | 1998-12-09 | — | — | EP | claimed |
| EP-0524692-B1 | Photochromatic and thermochromatic compounds and their application in polymeric materials | GREAT LAKES CHEMICAL ITALIA (IT) | 1997-12-17 | — | — | EP | claimed |
| US-5652246-A | NEUROKININ RECEPTOR ANTAGONISTS; NERVOUS SYSTEM DISORDERS | ADIR ET COMPAGNIE (FR) | 1997-07-29 | — | — | US | claimed |
| US-4493840-A | Antisecretory guanidine derivatives, and pharmaceutical compositions containing them | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1985-01-15 | — | — | US | claimed |
| US-4293555-A | OXAPENICILLIN ANTIBIOTICS | MERCK & CO., INC. (US) | 1981-10-06 | — | — | US | claimed |
| EP-0002210-A1 | 6- and 6,6- disubstituted-2-substituted-pen-2-em-3-carboxylic acids; processes for their preparation and pharmaceutical compositions containing such compounds | MERCK & CO. INC. (US) | 1979-06-13 | — | — | EP | claimed |
| US-4069337-A | 2-SUBSTITUTED-INDOLE-1-LOWER-ALKANECARBOXAMIDES HAVING ANTI-SECRETORY OR ANTI-ULCER ACTIVITY | STERLING DRUG INC. (US) | 1978-01-17 | — | — | US | claimed |
| US-4021448-A | ANTISECRETORY AND ANTIULCER ACTIVITIES | STERLING DRUG INC. (US) | 1977-05-03 | — | — | US | claimed |